Risk Stratification for Postoperative Acute Kidney Injury in Major Noncardiac Surgery Using Preoperative and Intraoperative Data.


Journal

JAMA network open
ISSN: 2574-3805
Titre abrégé: JAMA Netw Open
Pays: United States
ID NLM: 101729235

Informations de publication

Date de publication:
02 12 2019
Historique:
entrez: 7 12 2019
pubmed: 7 12 2019
medline: 24 6 2020
Statut: epublish

Résumé

Acute kidney injury (AKI) is one of the most common complications after noncardiac surgery. Yet current postoperative AKI risk stratification models have substantial limitations, such as limited use of perioperative data. To examine whether adding preoperative and intraoperative data is associated with improved prediction of noncardiac postoperative AKI. A prognostic study using logistic regression with elastic net selection, gradient boosting machine (GBM), and random forest approaches was conducted at 4 tertiary academic hospitals in the United States. A total of 42 615 hospitalized adults with serum creatinine measurements who underwent major noncardiac surgery between January 1, 2014, and April 30, 2018, were included in the study. Serum creatinine measurements from 365 days before and 7 days after surgery were used in this study. Postoperative AKI (defined by the Kidney Disease Improving Global Outcomes within 7 days after surgery) was the primary outcome. The area under the receiver operating characteristic curve (AUC) was used to assess discrimination. Among 42 615 patients who underwent noncardiac surgery, the mean (SD) age was 57.9 (15.7) years, 23 943 (56.2%) were women, 27 857 (65.4%) were white, and the most frequent surgery types were orthopedic (15 718 [36.9%]), general (8808 [20.7%]), and neurologic (6564 [15.4%]). The rate of postoperative AKI was 10.1% (n = 4318). The progressive addition of clinical data improved model performance across all modeling approaches, with GBM providing the highest discrimination by AUC. In GBM models, the AUC increased from 0.712 (95% CI, 0.694-0.731) using prehospitalization variables to 0.804 (95% CI, 0.788-0.819) using preoperative variables (inclusive of prehospitalization variables) (P < .001 for AUC comparison). The AUC further increased to 0.817 (95% CI, 0.802-0.832) when adding intraoperative variables (P < .001 for comparison vs model using preoperative variables). However, the statistically significant improvements in discrimination did not appear to be clinically significant. In particular, the AKI rate among patients classified as high risk improved from 29.1% to 30.0%, a net of 15 patients were appropriately reclassified as high risk, and an additional 15 patients were appropriately reclassified as low risk. The findings of the study suggest that electronic health record data may be used to accurately stratify patients at risk of perioperative AKI, but the modest improvements from adding intraoperative data should be weighed against challenges in using intraoperative data.

Identifiants

pubmed: 31808922
pii: 2757251
doi: 10.1001/jamanetworkopen.2019.16921
pmc: PMC6902769
doi:

Substances chimiques

Creatinine AYI8EX34EU

Types de publication

Journal Article Multicenter Study Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1916921

Subventions

Organisme : NIDDK NIH HHS
ID : K23 DK114526
Pays : United States

Références

Crit Care Med. 2018 Jul;46(7):1070-1077
pubmed: 29596073
Best Pract Res Clin Anaesthesiol. 2011 Dec;25(4):489-98
pubmed: 22099915
Anesthesiology. 2007 Dec;107(6):892-902
pubmed: 18043057
Am J Surg. 2014 Jan;207(1):53-9
pubmed: 24050540
Crit Care. 2013 Jun 20;17(3):R112
pubmed: 23787055
BMC Nephrol. 2014 Oct 23;15:169
pubmed: 25342079
Am J Kidney Dis. 2016 Jun;67(6):872-80
pubmed: 26337133
JAMA. 2017 Mar 14;317(10):1068-1069
pubmed: 28291878
Nephron Clin Pract. 2012;120(4):c179-84
pubmed: 22890468
Stat Appl Genet Mol Biol. 2007;6:Article25
pubmed: 17910531
Crit Care. 2007;11(2):R31
pubmed: 17331245
Med Care. 2005 Nov;43(11):1130-9
pubmed: 16224307
Ann Intern Med. 2015 Jan 6;162(1):55-63
pubmed: 25560714
Sci Rep. 2018 Nov 23;8(1):17298
pubmed: 30470779
PLoS Med. 2018 Nov 27;15(11):e1002703
pubmed: 30481186
Clin J Am Soc Nephrol. 2011 Jul;6(7):1731-8
pubmed: 21734089
Am J Kidney Dis. 2018 Mar;71(3 Suppl 1):A7
pubmed: 29477157
Crit Care. 2004 Aug;8(4):R204-12
pubmed: 15312219
JAMA. 2017 Nov 14;318(18):1787-1797
pubmed: 29136443
PLoS One. 2019 Apr 4;14(4):e0214904
pubmed: 30947282
Anesthesiology. 2018 Oct;129(4):649-662
pubmed: 29664888
Anesthesiology. 1978 Oct;49(4):233-6
pubmed: 697075
Anesthesiology. 2009 Mar;110(3):505-15
pubmed: 19212261
Biometrics. 1988 Sep;44(3):837-45
pubmed: 3203132
BMC Med Inform Decis Mak. 2016 Mar 29;16:39
pubmed: 27025458

Auteurs

Victor J Lei (VJ)

Department of Medical Ethics and Health Policy, University of Pennsylvania Perelman School of Medicine, Philadelphia.
Leonard Davis Institute of Health Economics, University of Pennsylvania Perelman School of Medicine, Philadelphia.

ThaiBinh Luong (T)

Predictive Healthcare, University of Pennsylvania Health System, Philadelphia.

Eric Shan (E)

University of Pennsylvania, Philadelphia.

Xinwei Chen (X)

Leonard Davis Institute of Health Economics, University of Pennsylvania Perelman School of Medicine, Philadelphia.

Mark D Neuman (MD)

Leonard Davis Institute of Health Economics, University of Pennsylvania Perelman School of Medicine, Philadelphia.
Department of Anesthesiology and Critical Care, University of Pennsylvania Health System, Philadelphia.

Nwamaka D Eneanya (ND)

Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania, Philadelphia.

Daniel E Polsky (DE)

Leonard Davis Institute of Health Economics, University of Pennsylvania Perelman School of Medicine, Philadelphia.
The Wharton School, University of Pennsylvania, Philadelphia.

Kevin G Volpp (KG)

Department of Medical Ethics and Health Policy, University of Pennsylvania Perelman School of Medicine, Philadelphia.
Leonard Davis Institute of Health Economics, University of Pennsylvania Perelman School of Medicine, Philadelphia.
The Wharton School, University of Pennsylvania, Philadelphia.
Corporal Michael J. Cresencz Veterans Affairs Medical Center, Department of Veterans Affairs, Philadelphia, Pennsylvania.

Lee A Fleisher (LA)

Leonard Davis Institute of Health Economics, University of Pennsylvania Perelman School of Medicine, Philadelphia.
Department of Anesthesiology and Critical Care, University of Pennsylvania Health System, Philadelphia.

John H Holmes (JH)

Leonard Davis Institute of Health Economics, University of Pennsylvania Perelman School of Medicine, Philadelphia.
Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania, Philadelphia.

Amol S Navathe (AS)

Department of Medical Ethics and Health Policy, University of Pennsylvania Perelman School of Medicine, Philadelphia.
Leonard Davis Institute of Health Economics, University of Pennsylvania Perelman School of Medicine, Philadelphia.
The Wharton School, University of Pennsylvania, Philadelphia.
Corporal Michael J. Cresencz Veterans Affairs Medical Center, Department of Veterans Affairs, Philadelphia, Pennsylvania.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH